Impax Asset Management Group plc Grows Stock Position in Intuitive Surgical, Inc. $ISRG

Impax Asset Management Group plc grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 133,228 shares of the medical equipment provider’s stock after acquiring an additional 5,515 shares during the period. Impax Asset Management Group plc’s holdings in Intuitive Surgical were worth $71,710,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Kaizen Financial Strategies purchased a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $220,000. Calamos Advisors LLC lifted its holdings in shares of Intuitive Surgical by 11.6% in the second quarter. Calamos Advisors LLC now owns 126,302 shares of the medical equipment provider’s stock valued at $68,634,000 after purchasing an additional 13,138 shares in the last quarter. Police & Firemen s Retirement System of New Jersey grew its holdings in Intuitive Surgical by 5.4% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 54,174 shares of the medical equipment provider’s stock valued at $29,439,000 after buying an additional 2,754 shares during the last quarter. Geode Capital Management LLC raised its stake in Intuitive Surgical by 1.4% in the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock valued at $4,429,590,000 after purchasing an additional 109,904 shares during the last quarter. Finally, Tobam lifted its stake in shares of Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 0.0%

Shares of NASDAQ:ISRG opened at $572.45 on Thursday. The firm has a 50-day simple moving average of $478.64 and a 200 day simple moving average of $502.49. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The company has a market cap of $205.21 billion, a PE ratio of 75.72, a P/E/G ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business’s revenue was up 22.9% compared to the same quarter last year. During the same period in the prior year, the company earned $1.84 earnings per share. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 105 shares of Intuitive Surgical stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $560.00, for a total transaction of $58,800.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Fredrik Widman sold 2,067 shares of the business’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $550.00, for a total value of $1,136,850.00. Following the transaction, the vice president owned 473 shares of the company’s stock, valued at approximately $260,150. This represents a 81.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 101,683 shares of company stock worth $53,517,192 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have commented on the company. Wells Fargo & Company lifted their price target on Intuitive Surgical from $599.00 to $600.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. HSBC upped their target price on shares of Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Mizuho set a $575.00 price objective on Intuitive Surgical in a report on Wednesday, October 22nd. Robert W. Baird set a $655.00 target price on Intuitive Surgical in a research report on Wednesday, October 22nd. Finally, Argus lifted their price target on shares of Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $608.92.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.